Feinstein Institutes Wins $3.37M Grant to Boost First-Responder Mental Health
MANHASSET, N.Y. — November 27, 2025: Feinstein Institutes for Medical Research, in collaboration with Stony Brook University and Texas...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
MANHASSET, N.Y. — November 27, 2025: Feinstein Institutes for Medical Research, in collaboration with Stony Brook University and Texas...
YONGIN, South Korea — November 27, 2025: GC Genome has announced the publication of its landmark study on a...
